These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23470236)

  • 1. Successful vaccination of immune suppressed recipients using Listeria vector HIV-1 vaccines in helminth infected mice.
    Shollenberger LM; Bui C; Paterson Y; Allen K; Harn D
    Vaccine; 2013 Apr; 31(16):2050-6. PubMed ID: 23470236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 vaccine-specific responses induced by Listeria vector vaccines are maintained in mice subsequently infected with a model helminth parasite, Schistosoma mansoni.
    Shollenberger LM; Bui CT; Paterson Y; Nyhoff L; Harn DA
    Vaccine; 2013 Nov; 31(48):5651-8. PubMed ID: 24120546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helminth infection suppresses T-cell immune response to HIV-DNA-based vaccine in mice.
    Da'Dara AA; Lautsch N; Dudek T; Novitsky V; Lee TH; Essex M; Harn DA
    Vaccine; 2006 Jun; 24(24):5211-9. PubMed ID: 16675073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.
    Dzhivhuho GA; Rehrl SA; Ndlovu H; Horsnell WGC; Brombacher F; Williamson AL; Chege GK
    PLoS Pathog; 2018 Jul; 14(7):e1007182. PubMed ID: 30048550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma mansoni soluble egg antigens enhance Listeria monocytogenes vector HIV-1 vaccine induction of cytotoxic T cells.
    Bui CT; Shollenberger LM; Paterson Y; Harn DA
    Clin Vaccine Immunol; 2014 Sep; 21(9):1232-9. PubMed ID: 24990901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Listeria monocytogenes as an alternative vaccine vector for HIV.
    Mata M; Paterson Y
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):151-62. PubMed ID: 10912619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10.
    Da'dara AA; Harn DA
    Vaccine; 2010 Feb; 28(5):1310-7. PubMed ID: 19941988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells.
    Wee EG; Ondondo B; Berglund P; Archer J; McMichael AJ; Baltimore D; Ter Meulen JH; Hanke T
    Mol Ther; 2017 Feb; 25(2):494-503. PubMed ID: 28153096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.
    Jongwe TI; Chapman R; Douglass N; Chetty S; Chege G; Williamson AL
    PLoS One; 2016; 11(7):e0159141. PubMed ID: 27427967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
    Shata MT; Hone DM
    J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys.
    Jiang S; Rasmussen RA; Nolan KM; Frankel FR; Lieberman J; McClure HM; Williams KM; Babu US; Raybourne RB; Strobert E; Ruprecht RM
    Vaccine; 2007 Oct; 25(42):7470-9. PubMed ID: 17854955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus.
    Rayevskaya M; Kushnir N; Frankel FR
    J Virol; 2002 Jan; 76(2):918-22. PubMed ID: 11752181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adenovirus in vaccines for HIV.
    Patterson S; Papagatsias T; Benlahrech A
    Handb Exp Pharmacol; 2009; (188):275-93. PubMed ID: 19031031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.
    Chin'ombe N
    Viruses; 2013 Aug; 5(9):2062-78. PubMed ID: 23989890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
    Newman MJ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiny steps towards an HIV vaccine.
    Willyard C
    Nature; 2010 Jul; 466(7304):S8. PubMed ID: 20631706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.